Loading...
Heterogeneous Binding and Central Nervous System Distribution of the Multitargeted Kinase Inhibitor Ponatinib Restrict Orthotopic Efficacy in a Patient-Derived Xenograft Model of Glioblastoma
This study investigated how differences in drug distribution and free fraction at different tumor and tissue sites influence the efficacy of the multikinase inhibitor ponatinib in a patient-derived xenograft model of glioblastoma (GBM). Efficacy studies in GBM6 flank (heterotopic) and intracranial (...
Na minha lista:
| Udgivet i: | J Pharmacol Exp Ther |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The American Society for Pharmacology and Experimental Therapeutics
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5625285/ https://ncbi.nlm.nih.gov/pubmed/28847917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.117.243477 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|